144Accepted Jul 18, 9:31 PM ET
BridgeBio Pharma, Inc. 144
Viking Global Opportunities Illiquid Investments Sub-Master LP
Accepted (ET)
9:31 PM
Jul 18, 2023
Filed
Jul 18, 2023
Documents
1
Size
6.6 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.